{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:20:50Z","timestamp":1778656850106,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tmaid.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T03:26:00Z","timestamp":1468725960000},"page":"373-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-5011","authenticated-orcid":false,"given":"Christian","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2016.07.003_bib1","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera (seminar)","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2016.07.003_bib2","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib3","first-page":"293","article-title":"Cholera: global surveillance summary 2009","volume":"85","author":"World Health Organisation","year":"2010","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib4","first-page":"289","article-title":"Cholera, 2011","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib5","first-page":"117","article-title":"Cholera vaccines \u2013 WHO position paper","volume":"85","author":"World Health Organisation","year":"2010","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4172\/2157-7560.1000183","article-title":"Managing cholera as a preventable global threat","volume":"4","author":"Thompson","year":"2013","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.tmaid.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-3099(15)00298-4","article-title":"The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans","volume":"16","author":"Deen","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11908-014-0455-4","article-title":"Cholera in travelers: shifting tides in epidemiology, management, and prevention","volume":"17","author":"Fillion","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.tmaid.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tmaid.2015.11.006","article-title":"Pre-travel health advice guidelines for humanitarian workers: a systematic review","volume":"13","author":"Costa","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib10","series-title":"Vaccines","first-page":"141","article-title":"Cholera vaccines","author":"Clemens","year":"2013"},{"key":"10.1016\/j.tmaid.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0264-410X(93)90019-T","article-title":"Live oral vaccines against cholera: an update","volume":"11","author":"Levine","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2217\/FMB.15.51","article-title":"Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine","volume":"10","author":"Jackson","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.tmaid.2016.07.003_bib13","first-page":"293","article-title":"Cholera, 2009","volume":"85","author":"World Health Organisation","year":"2010","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"e1001867","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings \u2013 a modeling study","volume":"12","author":"Azman","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tmaid.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib18","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak?","volume":"22","author":"Calain","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib19","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single dose live oral cholera vaccine CVD 103-HgR in North Jakarta Indonesia, a cholera endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell bank","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tmaid.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/iai.64.4.1454-1457.1996","article-title":"Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines","volume":"64","author":"Kollaritsch","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.tmaid.2016.07.003_bib22","first-page":"522","article-title":"Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated cholera CVD103-HgR and typhoid Ty21a vaccines","volume":"179","author":"Tsai","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1477-8939(03)00062-0","article-title":"Cholera: assessing the risk to travellers and identifying methods of protection","volume":"1","author":"Steffen","year":"2003","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2016.07.003_bib24","first-page":"297","article-title":"Cholera 2005","volume":"81","author":"World Health Organisation","year":"2006","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0264-410X(95)00218-P","article-title":"Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD 103-HgR","volume":"14","author":"Favre","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib26","unstructured":"A phase 3 lot to lot consistency study of live oral cholera vaccine, PXVX200 in healthy adults. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02094586?term=NCT02094586&rank=1 [Last accessed: 3.05.16]."},{"key":"10.1016\/j.tmaid.2016.07.003_bib27","unstructured":"A study of live oral cholera vaccine, PXVX200 in healthy older adults. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02100631?term=NCT02100631&rank=1 [Last accessed: 3.05.16]."},{"key":"10.1016\/j.tmaid.2016.07.003_bib28","unstructured":"Vaxchora Prescribing Information (June 2016). Available from: http:\/\/www.vaxchora.com\/Vaxchora_Prescribing_information.pdf [Last accessed: 7.07.16]."},{"key":"10.1016\/j.tmaid.2016.07.003_bib29","unstructured":"PXVX0200 (CVD103-HgR) vs Shanchol in Mali. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02145377?term=NCT02145377&rank=1 [Last accessed: 3.05.16]."},{"key":"10.1016\/j.tmaid.2016.07.003_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMp1214179","article-title":"The cure for cholera \u2013improving access to safe water","volume":"368","author":"Waldman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib31","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMp1402837","article-title":"Embracing oral cholera vaccine \u2013 the shifting response to cholera","volume":"370","author":"Pape","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(15)60246-X","article-title":"Oral cholera vaccines in endemic countries","volume":"386","author":"O'Leary","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2016.07.003_bib33","first-page":"517","article-title":"Cholera 2014","volume":"90","author":"World Health Organisation","year":"2015","journal-title":"Wkly Epid Rec"},{"key":"10.1016\/j.tmaid.2016.07.003_bib34","doi-asserted-by":"crossref","first-page":"e0135676","DOI":"10.1371\/journal.pone.0135676","article-title":"The impact of water, sanitation and hygiene interventions to control cholera \u2013 a systematic review","volume":"10","author":"Taylor","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tmaid.2016.07.003_bib35","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh \u2013 a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2016.07.003_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4269\/ajtmh.15-0700","article-title":"Effectiveness of oral cholera vaccine in Haiti: 37-Month follow-up","volume":"94","author":"S\u00e9v\u00e8re","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2016.07.003_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vaccine.2015.10.112","article-title":"Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand","volume":"34","author":"Phares","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2016.07.003_bib38","doi-asserted-by":"crossref","first-page":"e1001512","DOI":"10.1371\/journal.pmed.1001512","article-title":"Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea","volume":"10","author":"Ciglenecki","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib40","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.07.003_bib42","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cid\/ciw149","article-title":"Resurrecting a live oral cholera vaccine","volume":"62","author":"Harris","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893916300813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893916300813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:01Z","timestamp":1761487321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893916300813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1477893916300813"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2016.07.003","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}